Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats

Psychopharmacology

Volumn 233, Issue 7, 2016, Pages 1235-1243

  Papp, Mariusz ^a   Gruca, Piotr ^a   Lason Tyburkiewicz, Magdalena ^a   Willner, Paul ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Anhedonia; Cholinesterase inhibitors; Chronic mild stress; Donepezil; Imipramine; Memantine; Object recognition; Rat; Rivastigmine

Indexed keywords

DONEPEZIL; IMIPRAMINE; MEMANTINE; RIVASTIGMINE; ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC MILD STRESS; CHRONIC STRESS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; ELEVATED PLUS MAZE TEST; LOCOMOTION; MALE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; RAT; SUGAR INTAKE; TRANQUILIZING ACTIVITY; ANIMAL; COGNITIVE DYSFUNCTION; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; MENTAL STRESS; RECOGNITION; WISTAR RAT;

ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS; CHOLINESTERASE INHIBITORS; COGNITIVE DYSFUNCTION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; INDANS; MALE; NOOTROPIC AGENTS; PIPERIDINES; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); RIVASTIGMINE; STRESS, PSYCHOLOGICAL;

EID: 84954329055     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-016-4206-0     Document Type: Article

References (68)

1. Andreasen JT, Henningsen K, Bate S, Christiansen S, Wiborg O (2011) Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J Psychopharmacol 25:1134-1141
2. Aziz R, Steffens DC (2013) What are the causes of late-life depression? Psychiatr Clin N Am 36:497-516
3. Belzung C (2014) Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects? Neuropsychopharmacology 39:1041-1051
4. Bertoglio LJ, Carobrez AP (2003) Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology (Berlin) 170:335-342
5. Briones A, Gagno S, Martisova E, Dobarro M, Aisa B, Solas M, Tordera R, Ramírez M (2012) Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers. Br J Pharmacol 165:897-907
6. Calati R, Salvina Signorelli M, Balestri M, Marsano A, De Ronchi D, Aguglia E, Serretti A (2013) Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. J Affect Disord 147:1-8
7. Chen WQ, Yuan L, Xue R, Li YF, Su RB, Zhang YZ, Li J (2011) Repeated exposure to chlorpyrifos alters the performance of adolescent male rats in animal models of depression and anxiety. Neurotoxicology 32:355-361
8. Creeley C, Wozniak DF, Labruyere J, Taylor GT, Olney JW (2006) Low doses of memantine disrupt memory in adult rats. J Neurosci 26:3923-3932
9. Creeley CE, Wozniak DF, Nardi A, Farber NB, Olney JW (2008) Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain. Neurobiol Aging 29:153-167
10. Cuadrado-Tejedor M, Ricobaraza A, Frechilla D, Franco R, Pérez-Mediavilla A, Garcia-Osta A (2012) Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice. J Alzheimers Dis 28:567-578
11. Cummings JL, McRae T, Zhang R, Donepezil-Sertraline Study Group (2006) Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatr 14:605-612
12. Cutuli D, Foti F, Mandolesi L, De Bartolo P, Gelfo F, Federico F, Petrosini L (2008) Cognitive performance of healthy young rats following chronic donepezil administration. Psychopharmacology (Berlin) 197:661-673
13. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793-802
14. El-faramawy YA, El-banouby MH, Sergeev P, Mortagy AK, Amer MS, Abdel-tawab AM (2009) Changes in glutamate decarboxylase enzyme activity and tau-protein phosphorylation in the hippocampus of old rats exposed to chronic mild stress: reversal with the neuronal nitric oxide synthase inhibitor 7-nitroindazole. Pharmacol Biochem Behav 91:339-344
15. Elizalde N, Gil-Bea FJ, Ramírez MJ, Aisa B, Lasheras B, Del Rio J, Tordera RM (2008) Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berlin) 199:1-14
16. Farley S, Apazoglou K, Witkin JM, Giros B, Tzavara ET (2010) Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol 13:1207-1218
17. Ferguson SM, Brodkin JD, Lloyd GK, Menzaghi F (2000) Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Psychopharmacology (Berlin) 152:295-303
18. Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121-1129
19. Geoffroy M, Scheel-Krüger J, Christensen AV (1990) Effect of imipramine in the "learned helplessness" model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine. Psychopharmacology (Berlin) 101:371-375
20. Gideons ES, Kavalali ET, Monteggia LM (2014) Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci U S A 111:8649-8654
21. Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM (2011) The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 69:301-308
22. Hasselmann H (2014) Scopolamine and depression: a role for muscarinic antagonism? CNS Neurol Disord Drug Targets 13:673-683
23. Hoch PH, Mauss W (1932) Atropin Behandling bei Geisteckvankheiten. Arch Gen Psychatry 97:546-552
24. Holtzheimer PE, Mayberg HS (2011) Stuck in a rut: rethinking depression and its treatment. Trends Neurosci 34:1-9
25. Holtzheimer PE 3rd, Meeks TW, Kelley ME, Mufti M, Young R, McWhorter K, Vito N, Chismar R, Quinn S, Dey S, Byrd EH, McDonald WM (2008) A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. Int J Geriatr Psychiatry 23:625-631
26. Islam MR, Moriguchi S, Tagashira H, Fukunaga K (2014) Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice. Neuroscience 272:116-130
27. Janowsky DS, Risch SC (1984) Cholinomemetic and anticholinergic drugs used to ingestigae an acetylcholine hypothesis of affective disorders and stress. Drug Dev Res 4:125-142
28. Janowsky DS, El-Yousef MK, Davis JM (1974) Acetylcholine and depression. Psychosom Med 36:248-257
29. Karcz-Kubicha M, Jessa M, Nazar M, Plaznik A, Hartmann S, Parsons CG, Danysz W (1997) Anxiolytic activity of glycine-B antagonists and partial agonists - no relation to intrinsic activity in the patch clamp. Neuropharmacology 36:1355-1367
30. Kok RM, Nolen WA, Heeren TJ (2012) Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 141:103-115
31. Koltunowska D, Gibula-Bruzda E, Kotlinska JH (2013) The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Prog Neuropsychopharmacol Biol Psychiatry 45:242-249
32. Kotlinska J, Bochenski M (2008) The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats. Eur J Pharmacol 598:57-63
33. Lenze EJ, Skidmore ER, Begley AE, Newcomer JW, Butters MA, Whyte EM (2012) Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study. Int J Geriatr Psychiatry 27:974-980
34. Lisowski P, Wieczorek M, Goscik J, Juszczak GR, Stankiewicz AM, Zwierzchowski L, Swiergiel AH (2013) Effects of chronic stress on prefrontal cortex transcriptome in mice displaying different genetic backgrounds. J Mol Neurosci 50:33-57
35. Maratha SR, Mahadevan N (2012) Memory enhanding activity of naringin in unstressed and stressed mice: possible cholinergic and nitriergic modulation. Neurochem Res 37:2206-2212
36. Mayberg HS (2009) Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 119:717-725
37. McDermott CL, Gray SL (2012) Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression. Ann Pharmacother 46:599-605
38. Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, Picciotto MR (2013) Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc Natl Acad Sci U S A 110:3573-3578
39. Minkeviciene R, Banerjee P, Tanila H (2008) Cognition-enhancing and anxiolytic effects of memantine. Neuropharmacology 54:1079-1085
40. Mowla A, Mosavinasab M, Haghshenas H, Borhani Haghighi A (2007) Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol 27:484-487
41. Muhonen LH, Lönnqvist J, Juva K, Alho H (2008) Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry 69:392-399
42. Nakamura S, Tani Y, Maeeno Y, Ishihara T, Ohno T (1992) Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems. Pharmacol Biochem Behav 42:119-130
43. Omranifard V, Shirzadi E, Samandari S, Afshar H, Maracy MR (2014) Memantine add on to citalopram in elderly patients with depression: a double-blind placebo-controlled study. J Res Med 19:525-530
44. Orsetti M, Colella L, Dellarole A, Canonico PL, Ghi P (2007) Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats. Int J Neuropsychopharmacol 10:345-357
45. Papp M, Moryl E, Willner P (1996) Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296:129-136
46. Philip NS, Carpenter LL, Tyrka AR, Price LH (2010) Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berlin) 212:1-12
47. Quan MN, Zhang N, Wang YY, Zhang T, Yang Z (2011) Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model. Neuroscience 182:88-97
48. Réus GZ, Abelaira HM, Stringari RB, Fries GR, Kapczinski F, Quevedo J (2012) Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis 27:175-182
49. Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST (2011) Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 68:51-60
50. Rozzini L, Vicini Chilovi B, Bertoletti E, Trabucchi M, Padovani A (2007) Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. Aging Clin Exp Res 19:220-223
51. Sani G, Serra G, Kotzalidis GD, Romano S, Tamorri SM, Manfredi G, Caloro M, Telesforo CL, Caltagirone SS, Panaccione I, Simonetti A, Demontis F, Serra G, Girardi P (2012) The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence. CNS Drugs 26:663-690
52. Smith EG, Deligiannidis KM, Ulbricht CM, Landolin CS, Patel JK, Rothschild AJ (2013) Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 74:966-973
53. Solas M, Aisa B, Tordera RM, Mugueta MC, Ramírez MJ (2013) Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer's disease. Biochim Biophys Acta 1832:2332-2339
54. Spalletta G, Gianni W, Giubilei F, Casini AR, Sancesario G, Caltagirone C, Cravello L (2013) Rivastigmine patch ameliorates depression in mild AD: preliminary evidence from a 6-month open-label observational study. Alzheimer Dis Assoc Disord 27:289-291
55. Spalletta G, Caltagirone C, Padovani A, Sorbi S, Attar M, Colombo D, Cravello L, E V O L U T I O N study Working Group (2014) Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study. PLoS One 9(2):e89216
56. Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, Hen R, Belzung C (2008) Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 64:293-301
57. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR D Study Team (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am J Psychiatry 163:28-40
58. Wang C, Li M, Sawmiller D, Fan Y, Ma Y, Tan J, Ren Y, Li S (2014) Chronic mild stress-induced changes of risk assessment behaviors in mice are prevented by chronic treatment with fluoxetine but not diazepam. Pharmacol Biochem Behav 116:116-128
59. Weisenbach SL, Boore LA, Kales HC (2012) Depression and cognitive impairment in older adults. Curr Psychiatry Rep 14:280-288
60. Willner P (1997) Validity, reliability and utility of the chronic mild stress (CMS) model of depression: a ten-year review and evaluation. Psychopharmacology 134:319-329
61. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110
62. Willner P, Scheel-Kruger J, Belzung C (2013) The neuropharmacology of depression and antidepressant treatment. Neurosci Biobehav Rev 37:2331-2371
63. Willner P, Belzung C, Scheel-Kruger J (2014) Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm. Behav Pharmacol 25:352-371
64. Yang C, Guo X, Wang GH, Wang HL, Liu ZC, Liu H, Zhu ZX, Li Y (2014) Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress. Braz J Med Biol Res 47:237-244
65. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006a) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864
66. Zarate CA Jr, Singh JB, Quiroz JA, De Jesus G, Denicoff KK, Luckenbaugh DA, Manji HK, Charney DS (2006b) A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry 163:153-155
67. Zarrindast MR, Sroushi A, Bananej M, Vousooghi N, Hamidkhaniha S (2011) Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system. Eur J Pharmacol 672:106-112
68. Zurkovsky L, Taylor WD, Newhouse PA (2013) Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics. Biochem Pharmacol 86:1133-1144